Rapt Therapeutics Story

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;'>RT</div>
RAPT -- USA Stock  

USD 21.67  0.73  3.26%

Rapt Therapeutics Stock News module provides quick insight into current market opportunities from investing in Rapt Therapeutics. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Rapt Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly. Additionally, take a look at Rapt Therapeutics Hype Analysis, Rapt Therapeutics Correlation and Rapt Therapeutics Performance.

Search Today's Stock News

 
Refresh
Rapt Therapeutics stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Rapt Therapeutics daily returns and investor perception about the current pice of Rapt Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Purchase by Robbins Wendye of 500 shares of Rapt Therapeutics
Filed transaction by Rapt Therapeutics Inc director. General open market or private purchase of non-derivative or derivative security

Rapt Therapeutics insider trading alert for perchase of common stock by Robbins Wendye, the corporate stakeholder, on 16th of October 2020. This event was filed by Rapt Therapeutics Inc with SEC on 2020-10-16. Statement of changes in beneficial ownership - SEC Form 4

Current Valuation

Current Valuation Comparative Analysis

Rapt Therapeutics is currently under evaluation in current valuation category among related companies. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Additionally, take a look at Rapt Therapeutics Hype Analysis, Rapt Therapeutics Correlation and Rapt Therapeutics Performance. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.